Cargando…

Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists

BACKGROUND: It is not known if there is a differential impact on Alzheimer’s disease (AD) diagnosis and outcomes if/when patients are diagnosed with cognitive decline by specialists versus non-specialists. This study examined the cost trajectories of Medicare beneficiaries initially diagnosed by spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirson, Noam Y., Desai, Urvi, Ristovska, Ljubica, Cummings, Alice Kate G., Birnbaum, Howard G., Ye, Wenyu, Andrews, J. Scott, Ball, Daniel, Kahle-Wrobleski, Kristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940962/ https://www.ncbi.nlm.nih.gov/pubmed/27400711 http://dx.doi.org/10.1186/s12877-016-0303-5

Ejemplares similares

Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population-based survey
por: Andrews, J. Scott, et al.
Publicado: (2016)

Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease
por: Kirson, Noam Y., et al.
Publicado: (2017)

Disease severity at the time of initial cognitive assessment is related to prior health‐care resource use burden
por: Desai, Urvi, et al.
Publicado: (2020)

Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries
por: Desai, Urvi, et al.
Publicado: (2019)

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019)
por: Andrews, J. Scott, et al.
Publicado: (2023)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Andrews, J. Scott, et al.
Publicado: (2019)

Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
por: Happich, Michael, et al.
Publicado: (2016)

Estimating the health care burden of prescription opioid abuse in five European countries
por: Shei, Amie, et al.
Publicado: (2015)

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
por: Hadjiyianni, Irene, et al.
Publicado: (2016)

Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
por: Rice, J. Bradford, et al.
Publicado: (2014)

Characteristics of High-Cost Patients Diagnosed with Opioid Abuse
por: Shei, Amie, et al.
Publicado: (2015)

The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
por: Reinhart, Marcia, et al.
Publicado: (2018)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer’s disease patients
por: Gilden, Daniel M, et al.
Publicado: (2014)

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
por: Chandler, Julie, et al.
Publicado: (2022)

Modeling the course of Alzheimer's disease to improve clinical trials: symposium report
por: Spiegel, René, et al.
Publicado: (2013)

Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016)

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan
por: Montgomery, William, et al.
Publicado: (2018)

Alzheimer’s disease severity and its association with patient and caregiver quality of life in Japan: results of a community-based survey
por: Montgomery, William, et al.
Publicado: (2018)

Impact of caring for persons with Alzheimer’s disease or dementia on caregivers’ health outcomes: findings from a community based survey in Japan
por: Goren, Amir, et al.
Publicado: (2016)

The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: “What am I going to do?”
por: Stuckey, Heather L., et al.
Publicado: (2021)

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease
por: Lebrec, Jeremie, et al.
Publicado: (2016)

Understanding the Complexities of Functional Ability in Alzheimer’s Disease: More Than Just Basic and Instrumental Factors
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

The influence of caregivers and behavioral and psychological symptoms on nursing home placement of persons with Alzheimer’s disease: A matched case–control study
por: Porter, Candace N, et al.
Publicado: (2016)

Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England
por: Dell’Agnello, Grazia, et al.
Publicado: (2018)

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model
por: Furiak, Nicolas M, et al.
Publicado: (2010)

Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
por: Reed, Catherine, et al.
Publicado: (2018)

The social and economic burden of frontotemporal degeneration
por: Galvin, James E., et al.
Publicado: (2017)

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

Economic burden of dengue in Indonesia
por: Nadjib, Mardiati, et al.
Publicado: (2019)

Financing Drug Innovation in the US: Current Framework and Emerging Challenges
por: Cutler, David, et al.
Publicado: (2020)

Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis
por: Yu, Yanni F., et al.
Publicado: (2016)

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain
por: Escobar, Carlos, et al.
Publicado: (2023)

The economic burden of prostate cancer in Eswatini
por: Ngcamphalala, Cebisile, et al.
Publicado: (2022)

The Economic Burden of Dengue
por: Gubler, Duane J.
Publicado: (2012)

Diagnosing slipped capital femoral epiphysis amongst various medical specialists
por: Lam, A., et al.
Publicado: (2018)

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
por: Morgan, Alice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p47e8qqdrvbv9p9vbd2qv5uqfs